Abstract: Sulforaphane (SFN), a phytochemical found in broccoli and other cruciferous vegetables, is a potent antioxidant and anti-inflammatory agent with reported effects in cancer chemoprevention and suppression of infection with intracellular pathogens. Here we report on the impact of SFN on infection with Chlamydia trachomatis (Ct), a common sexually transmitted pathogen responsible for 131 million new cases annually worldwide. Astoundingly, we find that SFN as well as broccoli sprouts extract (BSE) promote Ct infection of human host cells. Both the number and size of Ct inclusions were increased when host cells were pretreated with SFN or BSE. The initial investigations presented here point to both the antioxidant and thiol alkylating properties of SFN as regulators of Ct infection. SFN decreased mitochondrial protein sulfenylation and promoted Ct development, which were both reversed by treatment with mitochondria-targeted paraquat (MitoPQ). Inhibition of the complement component 3 (complement C3) by SFN was also identified as a mechanism by which SFN promotes Ct infections. Mass spectrometry analysis found alkylation of cysteine 1010 (Cys1010) in complement C3 by SFN. The studies reported here raise awareness of the Ct infection promoting activity of SFN, and also identify potential mechanisms underlying this activity.
Introduction
Chlamydia trachomatis (Ct) is the most commonly reported sexually transmitted infection in the United States. 1 Approximately 131 million people are infected with Ct every year with women being diagnosed three times more often than men. 1, 2 Ct is obligate intracellular bacteria with a biphasic developmental cycle. [3] [4] [5] [6] [7] Elementary bodies (EBs, 0.3 μm size) are the infectious, metabolically repressed form of Ct that differentiates in the host cell into the metabolically active reticulate bodies (RBs, 1 μm size). RBs multiply within protective intracellular vacuoles called inclusions. At approximately 24 h post-infection (hpi), RBs asynchronously re-differentiate back to infectious EBs, which are then released from the host cells through extrusion or cell lysis for the next round of infection. 8 Under certain conditions (nutrient deprivation, antibiotic treatment) the RBs can also differentiate into a form called persistent or aberrant bodies (ABs, 1.2-1.5 mm size). [3] [4] [5] [6] [7] The entire process of Ct development from attachment/entry to extrusion/lysis is regulated by an arsenal of Ct and host cell proteins. [9] [10] [11] [12] The overarching theme of our research is the discovery of chemical agents with activity against Ct infections. The current treatment of Ct infections consists of azithromycin or doxycycline antibiotics and costs $10-$20 per patient. However, recent reporting points to emerging concerns of resistance to antibiotic treatment in clinic, 13 bringing about the need for new, cost-effective, and affordable therapeutics. Naturally occurring compounds constitute a rich and diverse resource and have been used extensively to identify compounds with activity against bacterial infections, cancer, and other diseases. [14] [15] [16] Here we focused on sulforaphane (SFN), a phytochemical abundantly present in various cruciferous plants such as broccoli, cabbage, and Brussels sprouts. 17 Epidemiological studies over the last decades indicate that consumption of dietary supplements from cruciferous vegetables reduces the risk of prostate, breast, lung, and colorectal cancers. 18 In vitro and in vivo studies have also demonstrated inhibition of HIV, 19 HCV, 20 and Helicobacter pylori [21] [22] [23] infections by SFN. The most widely known mechanism of SFN action is through the activation of KEAP1/NRF2 system triggered by SFN reaction with key regulatory cysteine residues in KEAP1. 24 KEAP1 inactivation through this mechanism leads then to increased nuclear localization of NRF2 transcription factor and upregulation of a number of antioxidant proteins and phase II detoxification enzymes that are under the transcriptional control of NRF2. 25 Based on the reported anti-HIV, -HCV, and -H. pylori effects of SFN, our starting hypothesis for this study was that SFN would repress Ct infection. This hypothesis was also supported by the knowledge that Ct relies on thiol-mediated chemistry to enter the host cell 26, 27 and regulate its developmental cycle, 28 and that Ct upregulates host cell reactive oxygen species (ROS), which we and others thought to be needed for its intracellular development. 11, 29 Thus, given both the antioxidant and thiol-alkylating properties of SFN, we aimed to investigate the potential therapeutic capacity of SFN against Ct infections using pure SFN and SFN-containing broccoli sprouts extract (BSE) [ Fig. 1(a) ] to mimic dietary intake. The data showed that contrary to our hypothesis, SFN actually stimulated Ct infection and that this activity was dependent on both the mitochondrialocalized antioxidant properties of SFN as well as on its reactivity with a key cysteine thiol in the complement component 3 (complement C3) protein. This latter finding also points to a potential mechanism by which SFN exerts its anti-cancer properties through inhibition of the pro-tumorigenic complement system, which is a new discovery with broad implications in cancer prevention.
Results

SFN and BSE promote Ct infection
High-pressure liquid chromatography (HPLC) was used to quantify the amount of SFN in BSE obtained from 4 ounces of broccoli sprouts, a typical serving size in US markets [ Fig. 1(b) ]. This was found to correspond to 4.7 mg SFN/pound of broccoli sprouts or 1.4 mg SFN/mL BSE (0.8 μM SFN). Thus, the followup studies utilized low micromolar concentrations of SFN (0.5 μM) to examine the effect of SFN on Ct infection. This concentration is lower than what is being typically used to mimic nutritional levels (2-15 μM) 30 and within the levels typically measured in blood and urine (100 nM-2.5 μM).
30,31
To elucidate first the consequence of SFN treatment on Ct infection, HeLa cells were pretreated with either SFN or BSE for 24 h, followed by a 24 h infection with Ct. Pretreatment was used to mimic everyday SFN exposure brought on by supplementation with SFN and/or diet. At 24-and 36 h post-infection (hpi), the cells were imaged using an anti-chlamydial major outer membrane protein (MOMP) antibody to visualize and quantify the number and size of Ct inclusions. As shown in Figure 1 (c), there was a significant increase in both the size and number of Ct inclusions when the host cells were treated with SFN or BSE compared with control cells at both time points selected for analysis. Similarly, transmission electron microscopy (TEM) analysis showed bigger and more densely populated Ct inclusions in cells treated with either SFN or BSE compared to nontreated cells [ Fig. 1(d) ], a finding further confirmed by Western blot analysis of chlamydial HSP60 protein [ Fig. 1(e) ]. To further identify if the observed effects on inclusion size and number are derived from SFN regulation of EBs attachment and entry into the host cells, we performed an inside-out assay using confocal imaging at short timepoints of infection. The results showed no statistically significant difference in the ratio of attached to entered EBs at any of the time points investigated (0.25, 0.5, 1, and 2.5 hpi) while the expected decrease in this ratio was observed within each group over time as more EBs entered the cells [ Fig. 1(f ) ].
Mitochondria redox state drives Ct infection
We and others have previously reported an increase in intracellular ROS with Ct infection, 11, 29 leading to the initial thought that Ct-induced ROS may be needed for Ct infection and intracellular development. As the antioxidant activity of SFN has been soundly established in previous literature, [32] [33] [34] and the data in Figure 1 and number by Ct infection, consistent with data in Figure 1 . Using cells only infected with Ct as a reference, we quantified the effects of MitoPQ on Ct infection. Indeed, the increased protein sulfenylation resulting from MitoPQ treatment was associated with attenuated chlamydial infection marked by a drastic reduction in both the number and size of the inclusions [ Fig. 2(b) ]. The MitoPQ effect on extracellular EBs was also assessed by pretreating the cells with MitoPQ and removing it prior to infection with Ct. The results showed comparable levels of Ct suppression based on inclusion number and size leading to the conclusion that the effects of MitoPQ are indeed intracellular [ Fig. 2(c) ].
SFN also exerts its anti-Ct effects by alkylation and inhibition of complement C3
Previous redox proteomics studies in our group on a related project focusing on the mechanisms by which SFN exerts anti-cancer activity have shown a decrease in complement C3 sulfenylation when cells were treated with SFN and labeled with BP1, a biotin-tagged chemical probe for protein sulfenylation 38 (data not shown 41 C3b is further needed to cleave C5 into C5a and C5b, which together with other proteins form pores in the bacterial membranes causing the cells to swell and burst (alternative pathway). The thioester bond in C3b is surface exposed enabling binding of C3b to the surface of invading pathogens by reacting with protein amine (-NH 2 ), hydroxyl (-OH), or thiol groups (-SH) to form covalent amides, esters, or new thioester bonds, and release free -SH on Cys1010. The role of the complement system, specifically C3 in other Chlamydia species has been well established (e.g., C3-dependent upregulation of B and T cell response was shown to attenuate infection in a murine model of Chlamydia psittaci 42 ), but studies have focused primarily on complement activity in serum. Less research has been done in general to understand the intracellular function(s) and mechanism(s) of the complement system, and when available this is limited to immune cells. 43 Given the reliance of the complement system on thiol chemistry and the known reactivity of SFN with thiols, we hypothesized that SFN may exert its Ct promoting activity by targeting complement C3 within the infected cells. SFN mechanism of action may be through alkylation of reactive Cys1010 in C3(H 2 O), which could trap this cysteine blocking thioester formation and consequently C3 proteolysis into the C3a and C3b forms. To determine first whether there is a function of complement C3 in Ct infection, we treated the HeLa cells with compstatin, a complement C3 inhibitor, in increasing concentrations followed by incubation with Ct for 24 h. As shown in Figure 3(a) , both the number and size of Ct inclusions were significantly increased in compstatin-treated cells compared to Ct alone, whereas treatment with complement C3 showed significantly reduced Ct inclusion size and number compared to control Ct infection [ Fig. 3(b) ].
Upon finding with these two complementary assays that indeed complement C3 inhibits Ct infection, we sought to elucidate a potential mechanistic interaction between SFN and C3. First, we investigated if pretreatment of host cells with SFN or BSE would relieve the inhibitory effect of complement C3. Indeed, SFN as well as BSE increased both the number and size of Ct inclusions in infected cells when these were also treated with complement C3 [Fig. 4  (a) ]. To investigate the mechanisms of SFN interference with the activation of complement C3, we performed Western blot analysis of cell infected with Ct, treated with SFN, and treated with SFN prior to Ct infection. As shown in Figure 4 (b), Ct suppressed the overall levels of complement C3 and also induced proteolysis to a fragment resembling the size or iC3b, the inhibitory form of C3b which cannot participate in the formation of the membrane-associated attack complex, a key event in the destruction of infectious pathogens by the complement system. SFN pretreatment did not significantly impact this profile but yet it did suppress the anti-Ct effects of complement C3 [ Fig. 4(a) ]. As mentioned above, one of the mechanisms by which complement C3 exerts its function is through cleavage into C3a and C3b by C3 convertase, a process dependent on the presence of the thioester bond. The Cys1010 SFN alkylated state would not be susceptible to proteolytic cleavage as it cannot form the critical thioester with Gln1013 and would effectively block the activation of the complement cascade at C3. To investigate this potential mechanism, we analyzed the modification of C3 by SFN using mass spectrometry. The analysis identified Cys1010 as modified by SFN [ Fig. 4(c) ], suggesting SFN functions by trapping the Cys1010 thiol group, thus inactivating the unprocessed form of complement C3.
Discussion
In a previous study, we have shown that Ct infection activates epidermal growth factor receptor (EGFR), a hallmark of cancers associated with sexually transmitted infections (e.g., head and neck cancer, and cervical cancer), and increases intracellular level of ROS. 11 We proposed that these findings complemented by other observations such as induction of systemic inflammatory and innate immune response, induction of centrosome abnormalities and genome duplication, and the finding that Ct encodes its own HSP60, which interferes with host cell apoptosis and cellular senescence, [44] [45] [46] [47] support a potential role of Ct infections in cancer etiology. We also anticipated that effective therapies against Ct could also work as cancer chemopreventive agents for populations at risk for sexually transmitted infections. With this study, we set out to determine the effects of a naturally occurring compound, SFN, with documented activity in cancer prevention, on chlamydial infections using a Chlamydia trachomatis (Ct) model. Based on the mechanistically connected antioxidant and thiol alkylating activities of SFN, we hypothesized that SFN would inhibit Ct infection. This study demonstrates that on the contrary, dietary levels of SFN and BSE promote Ct infection acting primarily on the intracellular development of Ct (Fig. 1) . Thus, despite the inhibitory effects of SFN on certain bacteria and viruses, SFN has opposite impact on Ct infection. Then, we went on to determine the mechanisms by which SFN was promoting chlamydial infection by focusing on the known biological activity and chemistry of SFN as antioxidant and electrophile reacting with nucleophilic thiols, respectively. Consistent with previous literature, 35 SFN demonstrated mitochondrial antioxidant properties, which were linked here to its Ct promoting activity. This conclusion was further supported by the studies with the mitochondria-targeted pro-oxidant MitoPQ, which exerted an inhibitory effect on Ct infection (Fig. 2) . The anti-and pro-oxidant activities of SFN and MitoPQ, respectively, were monitored in Figure 2 with the mitochondria-targeted protein sulfenylation probe, DCP-NEt 2 C. 37 This probe was previously shown to not interfere with mitochondrial respiration, a key property to avoid potential artifacts. Efforts to monitor selectively H 2 O 2 levels in mitochondria with Orp1-roGFP 48 or HyPer 49 genetically encoded probes were not successful due to the interference of SFN reaction with the reactive thiols in these reporter proteins. Next, rather than focusing the studies on the wellestablished KEAP1/NRF2 pathway, we wanted to explore other potential protein targets of SFN. As described in the Results, we were guided toward the complement system and in particular complement C3 as a potential mechanistic target by other redox proteomics studies in our group. The initial experiments with a known complement C3 inhibitor, compstatin, or by treating cells with complement C3 confirmed the function of complement C3 in the partial suppression of Ct infection (Fig. 3) . While these experiments did not distinguish between extracellular and intracellular complement C3, the data in Figure 4 (b) show that these effects are at least partly mediated by the intracellular complement C3. Further mass spectrometry . Statistically significant decrease in both inclusion number and size was found in cells treated with complement C3 (*0.01 < P < 0.05, **0.001 < P < 0.01; n = 3). In both panels, chlamydial inclusions were visualized with anti-MOMP antibody (red) and host cell nuclei with DAPI (blue).
analysis identified the alkylation of reactive Cys1010 in complement C3 by SFN, presumably blocking the activation of the complement cascade at C3. Since in C3b the thioester bond is further exposed and susceptible to hydrolysis, 50 it is also possible that in vivo SFN could block the complement cascade at this step. Numerous questions remain to be addressed such as the detailed mechanisms by which Ct itself suppresses the activation of complement C3, whether SFN exerts its activity at other stages of complement activation. Noteworthy, thiol-disulfide chemistry is key to all stages of Ct infection and Ct expresses a number of thiol-disulfide oxidoreductases. 26, 51 It has been reported that within cells, proteins on the surface of Ct are primarily in reduced state. 52 Blocking of these thiols by SFN could also prevent opsonization by the complement system, though other amine or hydroxyl groups could react with the exposed thioester in C3b.
It is also possible that Ct would release its own proteases to target the complement system as has been suggested by recent studies. 53 Based on our results, we suggest that would be also possible to inhibit activation of the complement cascade at C3 with thiolalkylating electrophiles such as SFN. This mechanism will be further explored in future studies. Is the Ct-promoting mechanism of SFN relevant to population health? SFN absorption in the human body is determined by source, contents, formulations, and doses. 54 Only a relatively small proportion of dietary SFN is absorbed in tissue with nearly 80% of this being secreted in urine. 55 Given that Ct is a sexually transmitted disease, this may place people at a higher risk of Ct infection. The levels of SFN and its metabolites in blood and urine were measured in several studies and ranged from~100 nM to 2.5 μM (e.g., Refs. 30, 31 ), depending on the type of intervention, individual's metabolism, and to some extent the analytical methods used to measure these compounds. Thus, the concentration of SFN utilized in our studies (0.5 μM) is meaningful from a nutritional standpoint. Knowledge of the SFN effects on Ct infection may result in recommendations to limit the dietary consumption of high SFN-containing vegetables or supplements at a minimum during the antibiotic treatment of Ct infections.
From a broader perspective, there is also the important question of whether there is a relationship between the antioxidant effects of SFN, mitochondria redox state and complement C3. Several studies have established a correlation between ROS levels and complement C3 expression. Knockout of mitochondrial SOD2 in mice showed increased complement C3 protein in the brain under basal conditions, which was further enhanced after induction of transient focal cerebral ischemia. 56 This was also associated with increased 4-HNE adducts, biomarkers of lipid peroxidation often associated with activation of apoptosis signaling. 57 Interestingly, a study analyzing the effects of complement C3 knockout in mice in relation to retinal alterations with aging found decreased 4-HNE adducts, increased catalase and glutathione reductase antioxidant proteins, increased anti-apoptotic proteins survinin and Mcl1/Bak, and decreased pro-apoptotic Caspase 3 activity. 58 Thus, these two lines of evidence suggest a bidirectional relationship between intracellular ROS, specifically mitochondrial ROS, and the complement system. Novel inhibitors of the complement system and in particular C3 are highly sought after for numerous diseases including alleviation of inflammatory damage associated with aging, cancer development, and ischemiareperfusion injury affecting heart, liver and brain functions. 59 New analogs of compstatin continue to be developed against complement C3 as well as other inhibitors or biologics targeting other proteins in the complement cascade. 60 This makes our discovery of SFN covalent inhibition of the complement system significant to the broader body of studies on the complement system.
Materials and Methods
Reagents and chemicals
Antibodies were obtained from the following sources: goat anti-Chlamydia trachomatis MOMP (Meridian Life Sciences, Saco, ME), rhodamine red X conjugated anti-goat secondary antibody (Jackson Laboratories, West Grove, PA), anti-C3 
Cell culture
Chlamydia trachomatis (Ct) serovar D strain UW-3/ Cx and HeLa cells were purchased from ATCC, USA. HeLa cells were cultured in DMEM containing 10% FBS and maintained at 37 C and 5% CO 2 . Ct EBs were purified as previously described. 61 Briefly, HeLa cells were grown to 80% confluency and infected with Ct for 48 h in the presence of cycloheximide. Cells were then ruptured with autoclaved glass beads. Cell lysates were separated by centrifugation. The supernatant was then extracted and centrifuged at 20,000 g and 4 C for 30 min. The resulting bacterial pellet was suspended in ice-cold SPG, a crystallization stock solution consisting of succinic acid, sodium dihydrogen phosphate, and glycine, aliquoted and stored at −80 C until use.
Preparation of broccoli sprouts extract and quantification of SFN content
Broccoli sprouts were purchased from Sunny Creek Farm in Tryon, NC. Total 60 ounces of fresh broccoli sprouts were homogenized and filtered through 0.22 μm nylon filters (VWR, Radnor, PA) to obtain the broccoli sprouts extract (BSE). BSE was then lyophilized and stored at-80 C for further use. To measure SFN content, BSE was further purified using silica SPE (solid phase extraction) cartridge. The silica cartridge was conditioned with 4 mL of dichloromethane, 200 μL of BSE was loaded through the silica cartridges, then the silica cartridge was washed with 4.0 mL of ethyl acetate and the BSE was eluted with 4 mL of dichloromethane. The obtained extracts were evaporated to dryness in a vacuum oven at 45 C for 2 h, and re-dissolved with 100 μL of 20 mM ammonium formate. The basic reverse-phase chromatography was conducted using a Waters2695 HPLC and Xbridge C18, 3.5um, 4.6 × 150 mm column and a non-linear gradient of solvent A (2% acetonitrile, 5 mM ammonium formate, pH 10) and solvent B (90% acetonitrile, 5 mM ammonium formate, pH 10) at a flow rate of 0.5 mL/min: 0-6.5 min: 2-48% B; 6.5-7. 
Confocal microscopy
HeLa cells were seeded on 8-well EZ glass slide (Millipore, Temecula, CA) in 10% FBS containing DMEM (no antibiotics). Cells were pretreated and/or infected with Ct as indicated in each figure legend. Cells were washed with PBS and fixed in 4% paraformaldehyde for 15 min, washed three times with icecold PBS and permeabilized with 0.1% TritonX-100 for 10 min. Cells were further washed with PBS and blocked with 1% BSA for 1 h at room temperature. Cells were incubated with goat anti-Ct EB (Meridian Life Sciences, Saco, ME) targeting the major outer membrane protein (MOMP) overnight at 4 C, followed by addition of the rhodamine conjugated antigoat secondary antibody (Jackson Laboratories, West Grove, PA) for 1 h at room temperature. The slides were mounted with Vecta shield mounting medium containing DAPI for fluorescence staining of host cell nuclei (Vector Laboratories, Burlingame, CA) and #1.5 glass coverslips. Confocal imaging was performed using a Zeiss 880 scanning confocal inverted microscope at 405 nm (DAPI and DCP-NEt 2 C) and 561 nm (Ct inclusions) wavelengths. For the inside-out assay, staining of attached versus internalized EBs was done as described previously. 11 Briefly, HeLa cells were infected with Ct at different time points in the presence of either SFN or a vehicle control. Cells were then fixed in formaldehyde and blocked with BSA. Following blocking, a FITC conjugated anti-Ct was used to stain attached EBs. Cells were then washed and permeabilized with TritonX-100. Following permeabilization, cells were blocked again and probed with anti-MOMP for internalized EBs as described above.
Transmission electron microscopy
HeLa cells pretreated with SFN or BSE for 24 h were infected with Ct as described above. At 24 hpi, the cells were washed with PBS and fixed with 2.5% glutaraldehyde in 0.1 M Millonig's buffer (pH 7.3) for 1 h followed by addition of 1% osmium tetroxide in 0.1 M Millonig's buffer for 30 min. The cells were washed three times with 0.1 M Millonig's buffer and dehydrated with 50% and 100% ethanol. The cells were scraped and centrifuged to get a pellet. The pellets were processed in propylene oxide (ppo) two times 15 min each and further infiltrated with 1:1 solution of Spurr's resin and ppo for 1 h, followed by a 2:1 solution of resin and ppo for 2 h and finally into a pure solution of resin for 1 h. The resin infiltrated pellets were kept overnight in a 70 C oven and the pellets were sectioned into 90 nm thin sections using a Reichart-Jung ultramicrotome. Sections were stained with uranyl acetate and lead citrate and viewed under FEI Tecnai BioTwin electron microscope.
Mass spectrometry analysis of complement C3 alkylation by SFN Complement C3 (1.5 μM) was incubated with SFN at a molar ratio of 1:10 (C3/SFN) in 100 μL PBS buffer (pH 7.2) for 2 h at 37 C prior to in-solution digestion and MS analysis. In-solution digestion was carried out using trypsin (Thermo Scientific) at a ratio of 1:50 (w/w) at 37 C overnight. The reaction was stopped by adding formic acid at a final concentration of 1%. Prior to MS analysis, the peptides were desalted using Thermo Scientific Pierce C18 spin columns. Eluted peptides were dried using a vacuum centrifuge and then resuspended in 1% formic acid, 5% acetonitrile.
The resuspended peptides were analyzed using a Thermo Q Exactive HF Orbitrap mass spectrometer coupled with a Dionex Ultimate 3000 nanoLC system, which was equipped with an Acclaim PepMap100 Nano Trap Column, and an Acclaim PepMap RSLC chromatography nanocolumn. The peptides were separated using a flow rate of 300 nL/min and the follow- The significance of the difference of means was determined by paired t-test and P values < 0.05 were considered significant.
